LH vs. ABT
Compare and contrast key facts about Laboratory Corporation of America Holdings (LH) and Abbott Laboratories (ABT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LH or ABT.
Correlation
The correlation between LH and ABT is 0.38, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
LH vs. ABT - Performance Comparison
Loading data...
Key characteristics
LH:
0.85
ABT:
1.25
LH:
1.55
ABT:
1.85
LH:
1.19
ABT:
1.23
LH:
0.86
ABT:
1.01
LH:
3.86
ABT:
6.13
LH:
5.92%
ABT:
4.21%
LH:
24.10%
ABT:
20.72%
LH:
-96.05%
ABT:
-45.66%
LH:
-3.83%
ABT:
-7.54%
Fundamentals
LH:
$21.00B
ABT:
$229.64B
LH:
$8.67
ABT:
$7.70
LH:
28.94
ABT:
17.14
LH:
0.95
ABT:
4.17
LH:
1.59
ABT:
5.42
LH:
2.53
ABT:
4.75
LH:
$13.18B
ABT:
$42.34B
LH:
$3.61B
ABT:
$23.67B
LH:
$1.80B
ABT:
$11.20B
Returns By Period
In the year-to-date period, LH achieves a 9.33% return, which is significantly lower than ABT's 15.22% return. Over the past 10 years, LH has underperformed ABT with an annualized return of 9.95%, while ABT has yielded a comparatively higher 12.39% annualized return.
LH
9.33%
12.89%
2.95%
20.36%
13.09%
9.95%
ABT
15.22%
2.18%
11.93%
25.65%
9.01%
12.39%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
LH vs. ABT — Risk-Adjusted Performance Rank
LH
ABT
LH vs. ABT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Laboratory Corporation of America Holdings (LH) and Abbott Laboratories (ABT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Loading data...
Dividends
LH vs. ABT - Dividend Comparison
LH's dividend yield for the trailing twelve months is around 1.15%, less than ABT's 1.77% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
LH Laboratory Corporation of America Holdings | 1.15% | 1.26% | 1.18% | 0.92% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
ABT Abbott Laboratories | 1.77% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% |
Drawdowns
LH vs. ABT - Drawdown Comparison
The maximum LH drawdown since its inception was -96.05%, which is greater than ABT's maximum drawdown of -45.66%. Use the drawdown chart below to compare losses from any high point for LH and ABT. For additional features, visit the drawdowns tool.
Loading data...
Volatility
LH vs. ABT - Volatility Comparison
Laboratory Corporation of America Holdings (LH) has a higher volatility of 8.86% compared to Abbott Laboratories (ABT) at 5.09%. This indicates that LH's price experiences larger fluctuations and is considered to be riskier than ABT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading data...
Financials
LH vs. ABT - Financials Comparison
This section allows you to compare key financial metrics between Laboratory Corporation of America Holdings and Abbott Laboratories. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LH vs. ABT - Profitability Comparison
LH - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Laboratory Corporation of America Holdings reported a gross profit of 948.00M and revenue of 3.35B. Therefore, the gross margin over that period was 28.3%.
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a gross profit of 5.89B and revenue of 10.36B. Therefore, the gross margin over that period was 56.9%.
LH - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Laboratory Corporation of America Holdings reported an operating income of 326.00M and revenue of 3.35B, resulting in an operating margin of 9.8%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported an operating income of 1.69B and revenue of 10.36B, resulting in an operating margin of 16.3%.
LH - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Laboratory Corporation of America Holdings reported a net income of 212.80M and revenue of 3.35B, resulting in a net margin of 6.4%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Abbott Laboratories reported a net income of 1.33B and revenue of 10.36B, resulting in a net margin of 12.8%.